compound introduction
Palbociclib-d 8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has the potential for ER-positive and HER2-negative breast cancer research. Form:Solid IC50& Target:Cdk4/cyclin D3 9 nM (IC 50 ) Cdk4/cyclin D1 11 nM (IC 50 ) Cdk6/cyclin D2 16 nM (IC 50 ) DYRK1A 2000 nM (IC 50 ) MAPK 8000 nM (IC 50 )
